These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 9125861

  • 1. [Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].
    Okubo K, Ishitoya S, Maeda H, Suzuki Y, Arai Y.
    Nihon Hinyokika Gakkai Zasshi; 1997 Mar; 88(3):386-90. PubMed ID: 9125861
    [Abstract] [Full Text] [Related]

  • 2. Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract.
    Nonomura N, Ono Y, Nozawa M, Fukui T, Harada Y, Nishimura K, Takaha N, Takahara S, Okuyama A.
    Eur Urol; 2000 Dec; 38(6):701-4;discussion 705. PubMed ID: 11111187
    [Abstract] [Full Text] [Related]

  • 3. Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ.
    Sharpe JR, Duffy G, Chin JL.
    J Urol; 1993 Mar; 149(3):457-9; discussion 459-60. PubMed ID: 8437246
    [Abstract] [Full Text] [Related]

  • 4. Intrarenal bacillus Calmette-Guérin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure.
    Okubo K, Ichioka K, Terada N, Matsuta Y, Yoshimura K, Arai Y.
    BJU Int; 2001 Sep; 88(4):343-7. PubMed ID: 11564018
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ.
    Shapiro EY, Lipsky MJ, Cha DY, McKiernan JM, Benson MC, Gupta M.
    J Endourol; 2012 Dec; 26(12):1645-50. PubMed ID: 22834939
    [Abstract] [Full Text] [Related]

  • 6. Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract.
    Miyake H, Eto H, Hara S, Okada H, Kamidono S, Hara I.
    Int J Urol; 2002 Dec; 9(12):677-80. PubMed ID: 12492951
    [Abstract] [Full Text] [Related]

  • 7. Bacillus Calmette-Guérin instillation treatment for carcinoma in situ of the upper urinary tract.
    Nishino Y, Yamamoto N, Komeda H, Takahashi Y, Deguchi T.
    BJU Int; 2000 May; 85(7):799-801. PubMed ID: 10792155
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.
    Horiguchi H, Yoneyama T, Hatakeyama S, Tokui N, Sato T, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Hashimoto Y, Koie T, Yoshikawa K, Narita S, Kawaguchi T, Ohyama C.
    Med Oncol; 2018 Feb 26; 35(4):41. PubMed ID: 29480348
    [Abstract] [Full Text] [Related]

  • 11. [Treatment outcome of intrarenal Bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].
    Anan G, Suyama T, Takeuchi N, Nakamura K, Sakamoto S, Nihei N, Ichikawa T.
    Hinyokika Kiyo; 2013 May 26; 59(5):261-4. PubMed ID: 23719131
    [Abstract] [Full Text] [Related]

  • 12. [Carcinoma in situ of the urinary tract--in patients with positive cytologies of upper urinary tract samples].
    Kitamura Y, Kobayasi K, Suzuki K, Saito T, Komatsubara S, Watanabe M.
    Nihon Hinyokika Gakkai Zasshi; 2002 Jul 26; 93(5):621-6. PubMed ID: 12174638
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter.
    Irie A, Iwamura M, Kadowaki K, Ohkawa A, Uchida T, Baba S.
    Urology; 2002 Jan 26; 59(1):53-7. PubMed ID: 11796281
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
    Hayashida Y, Nomata K, Noguchi M, Eguchi J, Koga S, Yamashita S, Hayashi M, Kanatake H.
    Urology; 2004 Jun 26; 63(6):1084-8. PubMed ID: 15183955
    [Abstract] [Full Text] [Related]

  • 17. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
    Giannarini G, Birkhäuser FD, Recker F, Thalmann GN, Studer UE.
    Eur Urol; 2014 Apr 26; 65(4):825-31. PubMed ID: 24144432
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Management of primary upper urinary tract carcinoma in situ diagnosed by ureteroscopic biopsy: Is bacillus Calmette-Guerin an alternative to nephroureterectomy?
    Territo A, Fontanet S, Meneghetti I, Gallioli A, Sanguedolce F, Rodriguez-Faba Ó, Gaya JM, Palou J, Huguet J, Breda A.
    Actas Urol Esp (Engl Ed); 2023 May 26; 47(4):221-228. PubMed ID: 36379260
    [Abstract] [Full Text] [Related]

  • 20. Instillation of bacillus Calmette-Guerin into the renal pelvis of a solitary kidney for the treatment of transitional cell carcinoma.
    Ramsey JC, Soloway MS.
    J Urol; 1990 Jun 26; 143(6):1220-2. PubMed ID: 2342185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.